Home > News & Media > News
Communication starts here.
2022.04
TWi’ ANDA for Fluphenazine HCl Tablets (equivalent to Prolixin®) has been officially approved by US FDA
2022.03
TWi officially launches its Mycophenolic Acid Delayed-Release Tablets in TWi label
2021-01
TWi officially launches generic Dimethyl Fumarate DR Capsules in TWi label
2020-10
TWi’ ANDA for Dimethyl Fumarate DR Capsules (equivalent to Tecfidera®) has been officially approved by US FDA
2020.08
TWi officially launches generic Propafenone HCl ER Capsules in TWi label
2020.07
TWi officially launches generic Terbutaline Sulfate Tablets in TWi label
2020.07
TWi successfully launches generic Fenofibric Acid DR Capsules in TWi label
2020.06
TWi's ANDA for Terbutaline Sulfate Tablets (equivalent to Brethine®) has been officially approved by US FDA
2020.06
TWi's ANDA for Propafenone HCl ER Capsules (equivalent to Rythmol SR®) has been officially approved by US FDA
2020.03
TWi successfully launches generic Testosterone Gel 1.62% Pump CIII in TWi label

 

Pages:1 - 2 - 3 - 4 - 5 - 6 - 7« Pre · Next »